Agios Pharmaceuticals, Inc. (AGIO)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
11-Mar-24 4:09 PM
View: 
Foster-Cheek Kaye I
Director
Agios Pharmaceuticals, Inc. (AGIO) 07-Mar-24Sale 1,285$31.62$40,631.70(14%)
9.01K to 7.72K
07-Mar-24 6:49 PM
View: 
Foster-Cheek Kaye I
Director
Agios Pharmaceuticals, Inc. (AGIO) 06-Mar-24Sale 4,415$31.99$141,236.00(33%)
13.42K to 9.01K
05-Mar-24 4:08 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Planned Option Sale 2,642$32.57$86,049.90(7%)
39.81K to 37.17K
07-Mar-24 6:49 PM
View: 
Foster-Cheek Kaye I
Director
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Sale 300$32.21$9,663.00(2%)
13.72K to 13.42K
05-Mar-24 4:20 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Planned Option Sale 2,642$32.57$86,049.90(6%)
41.71K to 39.07K
05-Mar-24 4:10 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Planned Option Sale 4,156$32.57$135,361.00(7%)
57.94K to 53.78K
05-Mar-24 4:15 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Planned Option Sale 1,214$32.57$39,540.00(20%)
6.01K to 4.8K
05-Mar-24 4:18 PM
View: 
Jones Cecilia
Chief Financial Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Planned Option Sale 672$32.57$21,887.00(4%)
15.51K to 14.84K
07-Mar-24 6:47 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Mar-24Sale 1,913$31.75$60,737.80(40%)
4.8K to 2.89K
05-Mar-24 4:10 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 01-Mar-24Option Exercise 8,500----17%
49.44K to 57.94K
05-Mar-24 4:15 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 01-Mar-24Option Exercise 3,127----121%
2.59K to 5.72K
05-Mar-24 4:18 PM
View: 
Jones Cecilia
Chief Financial Officer
Agios Pharmaceuticals, Inc. (AGIO) 01-Mar-24Option Exercise 2,000----15%
13.51K to 15.51K
05-Mar-24 4:08 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 01-Mar-24Option Exercise 7,834----26%
30.68K to 38.52K
05-Mar-24 4:20 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 01-Mar-24Option Exercise 7,834----24%
32.58K to 40.41K
29-Feb-24 4:05 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 27-Feb-24Option Exercise 69,329$31.64$2,193,570.0015%
472.71K to 542.04K
29-Feb-24 4:05 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 27-Feb-24Option Sale 69,329$34.67$2,403,590.00(13%)
542.04K to 472.71K
27-Feb-24 4:04 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 26-Feb-24Option Exercise 20,411$31.64$645,804.004%
472.71K to 493.12K
27-Feb-24 4:04 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 26-Feb-24Option Sale 20,411$33.19$677,441.00(4%)
493.12K to 472.71K
27-Feb-24 4:04 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 23-Feb-24Option Exercise 47,731$31.64$1,510,210.0010%
472.71K to 520.44K
27-Feb-24 4:04 PM
View: 
Schenkein David P
Director
Agios Pharmaceuticals, Inc. (AGIO) 23-Feb-24Option Sale 47,731$33.05$1,577,510.00(9%)
520.44K to 472.71K
22-Feb-24 5:43 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 20-Feb-24Sale 504$26.63$13,421.50(16%)
3.25K to 2.74K
14-Feb-24 5:51 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 14-Feb-24Planned Option Sale 545$25.14$13,701.30(2%)
32.21K to 31.67K
14-Feb-24 5:50 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 14-Feb-24Planned Option Sale 273$25.14$6,863.22(8%)
3.52K to 3.25K
14-Feb-24 5:53 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 14-Feb-24Planned Option Sale 642$25.14$16,139.90(2%)
34.07K to 33.43K
14-Feb-24 5:50 PM
View: 
Washburn Theodore James Jr.
Principal Accounting Officer
Agios Pharmaceuticals, Inc. (AGIO) 12-Feb-24Option Exercise 777----28%
2.74K to 3.52K
14-Feb-24 5:51 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 12-Feb-24Option Exercise 1,833----6%
30.38K to 32.21K
14-Feb-24 5:53 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 12-Feb-24Option Exercise 2,162----7%
31.91K to 34.07K
24-Jan-24 4:23 PM
View: 
Jones Cecilia
Chief Financial Officer
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 1,886$21.64$40,813.00(13%)
14.96K to 13.07K
24-Jan-24 4:24 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 1,708$21.64$36,961.10(5%)
33.62K to 31.91K
24-Jan-24 4:22 PM
View: 
Fouse Jacqualyn A
Director
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 10,722$21.64$232,024.00(8%)
139.97K to 129.25K
24-Jan-24 4:20 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 7,635$21.64$165,221.00(13%)
57.07K to 49.44K
24-Jan-24 4:19 PM
View: 
Milanova Tsveta
Chief Commercial Officer
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 1,618$21.64$35,013.50(11%)
14.85K to 13.23K
24-Jan-24 4:25 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 24-Jan-24Planned Option Sale 1,708$21.64$36,961.10(5%)
32.09K to 30.38K
24-Jan-24 4:20 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 17,018----42%
40.05K to 57.07K
24-Jan-24 4:19 PM
View: 
Milanova Tsveta
Chief Commercial Officer
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 5,448----58%
9.4K to 14.85K
24-Jan-24 4:24 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 5,750----21%
27.87K to 33.62K
24-Jan-24 4:22 PM
View: 
Fouse Jacqualyn A
Director
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 23,900----21%
116.08K to 139.97K
24-Jan-24 4:23 PM
View: 
Jones Cecilia
Chief Financial Officer
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 5,380----56%
9.57K to 14.96K
24-Jan-24 4:25 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 20-Jan-24Option Exercise 5,750----22%
26.34K to 32.09K
09-Jan-24 4:26 PM
View: 
Fouse Jacqualyn A
Director
Agios Pharmaceuticals, Inc. (AGIO) 09-Jan-24Planned Option Sale 8,391$22.99$192,909.00(7%)
124.47K to 116.08K
09-Jan-24 4:28 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 09-Jan-24Planned Option Sale 12,066$22.99$277,397.00(23%)
52.12K to 40.05K
09-Jan-24 4:25 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 09-Jan-24Planned Option Sale 1,163$22.99$26,737.40(4%)
27.5K to 26.34K
09-Jan-24 4:22 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 09-Jan-24Planned Option Sale 1,789$22.99$41,129.10(6%)
29.66K to 27.87K
09-Jan-24 4:26 PM
View: 
Fouse Jacqualyn A
Director
Agios Pharmaceuticals, Inc. (AGIO) 05-Jan-24Option Exercise 17,500----16%
106.97K to 124.47K
05-Jan-24 4:10 PM
View: 
Milanova Tsveta
Chief Commercial Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Jan-24Planned Option Sale 2,902$22.32$64,772.60(24%)
12.31K to 9.4K
09-Jan-24 4:25 PM
View: 
Burns James William
Chief Legal Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Jan-24Option Exercise 3,250----13%
24.25K to 27.5K
09-Jan-24 4:28 PM
View: 
Goff Brian
Chief Executive Officer
Director
Agios Pharmaceuticals, Inc. (AGIO) 05-Jan-24Option Exercise 25,527----96%
26.59K to 52.12K
09-Jan-24 4:22 PM
View: 
Gheuens Sarah
Chief Medical Officer
Agios Pharmaceuticals, Inc. (AGIO) 05-Jan-24Option Exercise 5,000----20%
24.66K to 29.66K
05-Jan-24 4:10 PM
View: 
Milanova Tsveta
Chief Commercial Officer
Agios Pharmaceuticals, Inc. (AGIO) 03-Jan-24Option Exercise 8,475----221%
3.83K to 12.31K
28-Sep-23 4:02 PM
View: 
Jones Cecilia
Chief Financial Officer
Agios Pharmaceuticals, Inc. (AGIO) 28-Sep-23Planned Option Sale 2,179$24.79$54,017.40(19%)
11.75K to 9.57K